A detailed history of Deutsche Bank Ag\ transactions in Myriad Genetics Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 51,856 shares of MYGN stock, worth $664,793. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,856
Previous 40,192 29.02%
Holding current value
$664,793
Previous $983,000 44.35%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$23.97 - $28.6 $279,586 - $333,590
11,664 Added 29.02%
51,856 $1.42 Million
Q2 2024

Aug 14, 2024

SELL
$17.98 - $25.47 $57,571 - $81,554
-3,202 Reduced 7.38%
40,192 $983,000
Q1 2024

May 15, 2024

BUY
$17.59 - $23.59 $49,164 - $65,934
2,795 Added 6.88%
43,394 $925,000
Q4 2023

Feb 14, 2024

SELL
$13.91 - $21.32 $11,531 - $17,674
-829 Reduced 2.0%
40,599 $777,000
Q3 2023

Nov 09, 2023

BUY
$15.99 - $23.22 $41,925 - $60,882
2,622 Added 6.76%
41,428 $664,000
Q2 2023

Aug 14, 2023

SELL
$17.56 - $23.76 $417,049 - $564,300
-23,750 Reduced 37.97%
38,806 $899,000
Q1 2023

May 15, 2023

SELL
$15.26 - $23.75 $283,942 - $441,916
-18,607 Reduced 22.93%
62,556 $1.45 Million
Q4 2022

Feb 13, 2023

BUY
$14.51 - $20.99 $155,866 - $225,474
10,742 Added 15.25%
81,163 $1.18 Million
Q3 2022

Nov 14, 2022

SELL
$18.21 - $27.88 $150,997 - $231,180
-8,292 Reduced 10.53%
70,421 $1.34 Million
Q2 2022

Aug 11, 2022

SELL
$16.45 - $25.88 $1.1 Million - $1.73 Million
-66,806 Reduced 45.91%
78,713 $1.43 Million
Q1 2022

May 13, 2022

SELL
$22.67 - $28.01 $76,080 - $94,001
-3,356 Reduced 2.25%
145,519 $3.67 Million
Q4 2021

Feb 11, 2022

BUY
$24.13 - $32.63 $1.52 Million - $2.06 Million
63,016 Added 73.39%
148,875 $4.11 Million
Q3 2021

Nov 04, 2021

SELL
$29.97 - $36.66 $23,526 - $28,778
-785 Reduced 0.91%
85,859 $2.77 Million
Q2 2021

Aug 11, 2021

BUY
$25.39 - $32.61 $9,876 - $12,685
389 Added 0.45%
86,644 $2.65 Million
Q1 2021

May 13, 2021

SELL
$19.92 - $31.6 $226,769 - $359,734
-11,384 Reduced 11.66%
86,255 $2.63 Million
Q4 2020

Feb 16, 2021

BUY
$12.16 - $19.77 $162,396 - $264,028
13,355 Added 15.85%
97,639 $1.93 Million
Q3 2020

Nov 12, 2020

BUY
$11.25 - $14.75 $272,182 - $356,861
24,194 Added 40.26%
84,284 $1.1 Million
Q2 2020

Aug 13, 2020

SELL
$10.69 - $16.49 $2.28 Million - $3.52 Million
-213,614 Reduced 78.05%
60,090 $681,000
Q1 2020

May 14, 2020

SELL
$9.78 - $29.53 $23.8 Million - $71.9 Million
-2,433,922 Reduced 89.89%
273,704 $3.92 Million
Q4 2019

Feb 14, 2020

BUY
$20.93 - $35.1 $54.7 Million - $91.8 Million
2,615,041 Added 2824.48%
2,707,626 $73.7 Million
Q3 2019

Nov 14, 2019

SELL
$22.08 - $47.08 $2.43 Million - $5.19 Million
-110,267 Reduced 54.36%
92,585 $2.65 Million
Q2 2019

Aug 14, 2019

BUY
$22.67 - $35.0 $3.91 Million - $6.04 Million
172,431 Added 566.82%
202,852 $5.63 Million
Q1 2019

May 15, 2019

SELL
$26.93 - $34.7 $232,136 - $299,114
-8,620 Reduced 22.08%
30,421 $1.01 Million
Q4 2018

Feb 14, 2019

SELL
$27.23 - $45.56 $7.5 Million - $12.6 Million
-275,586 Reduced 87.59%
39,041 $1.13 Million
Q3 2018

Dec 21, 2021

BUY
$37.57 - $50.34 $5.48 Million - $7.35 Million
145,932 Added 86.51%
314,627 $14.5 Million
Q3 2018

Nov 14, 2018

SELL
$37.57 - $50.34 $4.23 Million - $5.66 Million
-112,524 Reduced 40.01%
168,695 $7.76 Million
Q2 2018

Apr 21, 2020

BUY
$27.75 - $40.17 $4.33 Million - $6.27 Million
155,985 Added 124.55%
281,219 $10.5 Million
Q2 2018

Aug 14, 2018

SELL
$27.75 - $40.17 $4.85 Million - $7.03 Million
-174,937 Reduced 58.28%
125,234 $4.68 Million
Q1 2018

Oct 18, 2019

BUY
$28.83 - $41.01 $6.16 Million - $8.77 Million
213,786 Added 247.48%
300,171 $8.87 Million
Q1 2018

May 15, 2018

SELL
$28.83 - $41.01 $4.4 Million - $6.26 Million
-152,766 Reduced 63.88%
86,385 $2.55 Million
Q4 2017

Feb 14, 2018

SELL
$28.45 - $37.14 $8.32 Million - $10.9 Million
-292,466 Reduced 55.01%
239,151 $8.21 Million
Q3 2017

Nov 14, 2017

BUY
$24.01 - $36.2 $12.8 Million - $19.2 Million
531,617
531,617 $19.2 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.03B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.